Skip to content

Clinical study for prevention of PICC-related venous thrombosis in patients with cancer by moxibustion

Clinical study for prevention of PICC-related venous thrombosis in patients with cancer by moxibustion

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024711
Enrollment
Unknown
Registered
2019-07-23
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

experimental group :A total of 8 points, including Binao, Quchi, Waiguan, Hegu, Shenshu, Qihai, Xuehai, and Zu sanli are selected for moxibustion treatment. Patients are treated with moxibustion for 2
control group:not used moxibustion

Sponsors

The First Afflicted Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1 adult patients aged 18 to 65 years; 2 patients with clear consciousness and able to express correctly; 3 patients with definite diagnosis of malignancy and the estimated survival time is more than 6 weeks; 4 patients with normal motor function and normal muscle strength, and no history of surgery and vascular disease in both upper limbs was reported.

Exclusion criteria

Exclusion criteria: 1 patients with coagulopathy; 2 patients who need anticoagulant for basic diseases; 3 patients who do not maintain the PICC in our hospital, or have intermittent maintenance and are not fully tracked; 4 patients who do not voluntarily join the study.

Design outcomes

Primary

MeasureTime frame
the rate of asympotomatic thrombosis;

Countries

China

Contacts

Public ContactQiu Ling

The First Afflicted Hospital of Guangzhou Medical University

295936293@qq.com+86 020-34297412

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026